Karyopharm to participate at upcoming investor conferences

Newton, mass. , sept. 5, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate in the following investor conferences in september: h.c.

KPTI Ratings Summary

KPTI Quant Ranking